Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Efficacy and Safety of Dexmedetomidine as an Adjuvant to Bupivacaine in Ultrasound-guided Quadratus Lumborum Versus Epidural Block for Postoperative Analgesia in Lower Abdominal Cancer Surgeries.

NCT06130670 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT06130670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06130670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Efficacy and Safety of Dexmedetomidine as an Adjuvant to Bupivacaine in Ultrasound-guided Quadratus Lumborum Versus Epidural Block for Postoperative Analgesia in Lower Abdominal Cancer Surgeries.
Lead sponsor
Assiut University
Phase
Not applicable
Overall status
Completed
Start date
April 20, 2024
Completion date
December 31, 2024
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

to compare efficacy of dexmedetomidine in bilateral quadratus lumborum vs lumbar epidural blocks on analgesia after major lower abdominal surgery